Psoriasis is a skin disease that affects about 8 million Americans ... Bimzelx was approved for the treatment of moderate or severe plaque psoriasis. If you have psoriasis under your arms ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

It’s wintertime in the Northern Hemisphere, and for many people that means having the spotlight on your body’s largest ...

Not a lot of people know about psoriasis which is why several myths and misconceptions about the condition continue to ...

These cells pile up on the skin’s surface ... as rheumatoid arthritis or Crohn’s disease. Biologics work differently than other available psoriasis treatments. They calm inflammation in ...

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

Discover studies that have shown that psoriasis patients exhibit elevated intestinal permeability, correlating with ...

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

In a new study, researchers at Case Western Reserve University School of Medicine have determined that a protein called NF-kB ...

Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and ...